ATRION CORPORATION (ATRI) Fundamental Analysis & Valuation

NASDAQ:ATRI • US0499041053

459.92 USD
+0.26 (+0.06%)
Last: Aug 20, 2024, 08:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

This ATRI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to ATRI. ATRI was compared to 184 industry peers in the Health Care Equipment & Supplies industry. ATRI has an excellent financial health rating, but there are some minor concerns on its profitability. ATRI is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. ATRI Profitability Analysis

1.1 Basic Checks

  • In the past year ATRI was profitable.
  • ATRI had a positive operating cash flow in the past year.
  • In the past 5 years ATRI has always been profitable.
  • In the past 5 years ATRI always reported a positive cash flow from operatings.
ATRI Yearly Net Income VS EBIT VS OCF VS FCFATRI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M 40M

1.2 Ratios

  • ATRI has a better Return On Assets (4.82%) than 82.72% of its industry peers.
  • Looking at the Return On Equity, with a value of 5.26%, ATRI is in the better half of the industry, outperforming 77.49% of the companies in the same industry.
  • With a decent Return On Invested Capital value of 5.13%, ATRI is doing good in the industry, outperforming 78.53% of the companies in the same industry.
  • Measured over the past 3 years, the Average Return On Invested Capital for ATRI is above the industry average of 9.15%.
  • The last Return On Invested Capital (5.13%) for ATRI is well below the 3 year average (11.35%), which needs to be investigated, but indicates that ATRI had better years and this may not be a problem.
Industry RankSector Rank
ROA 4.82%
ROE 5.26%
ROIC 5.13%
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
ATRI Yearly ROA, ROE, ROICATRI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 5 10 15

1.3 Margins

  • The Profit Margin of ATRI (6.92%) is better than 78.53% of its industry peers.
  • In the last couple of years the Profit Margin of ATRI has declined.
  • With a decent Operating Margin value of 7.93%, ATRI is doing good in the industry, outperforming 75.39% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ATRI has declined.
  • Looking at the Gross Margin, with a value of 32.08%, ATRI is doing worse than 72.25% of the companies in the same industry.
  • ATRI's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 7.93%
PM (TTM) 6.92%
GM 32.08%
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
ATRI Yearly Profit, Operating, Gross MarginsATRI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ATRI Health Analysis

2.1 Basic Checks

  • ATRI has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • Compared to 1 year ago, ATRI has less shares outstanding
  • There is no outstanding debt for ATRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
ATRI Yearly Shares OutstandingATRI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 500K 1M 1.5M
ATRI Yearly Total Debt VS Total AssetsATRI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

2.2 Solvency

  • ATRI has an Altman-Z score of 25.99. This indicates that ATRI is financially healthy and has little risk of bankruptcy at the moment.
  • The Altman-Z score of ATRI (25.99) is better than 95.29% of its industry peers.
  • There is no outstanding debt for ATRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 25.99
ROIC/WACC0.59
WACC8.7%
ATRI Yearly LT Debt VS Equity VS FCFATRI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M 150M 200M

2.3 Liquidity

  • ATRI has a Current Ratio of 6.80. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
  • ATRI has a better Current ratio (6.80) than 81.68% of its industry peers.
  • ATRI has a Quick Ratio of 2.94. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
  • ATRI has a better Quick ratio (2.94) than 61.78% of its industry peers.
Industry RankSector Rank
Current Ratio 6.8
Quick Ratio 2.94
ATRI Yearly Current Assets VS Current LiabilitesATRI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

1

3. ATRI Growth Analysis

3.1 Past

  • ATRI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.54%.
  • ATRI shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.39% yearly.
  • ATRI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.00%.
  • ATRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.13% yearly.
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ATRI Yearly Revenue VS EstimatesATRI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M

More info and screens

Find the best growth stocksShow best growing peers

3

4. ATRI Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 64.50, which means the current valuation is very expensive for ATRI.
  • Based on the Price/Earnings ratio, ATRI is valued a bit cheaper than 68.06% of the companies in the same industry.
  • When comparing the Price/Earnings ratio of ATRI to the average of the S&P500 Index (26.15), we can say ATRI is valued expensively.
Industry RankSector Rank
PE 64.5
Fwd PE N/A
ATRI Price Earnings VS Forward Price EarningsATRI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ATRI is valued a bit cheaper than 73.82% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, ATRI is valued cheaper than 84.29% of the companies in the same industry.
Industry RankSector Rank
P/FCF 29.25
EV/EBITDA 26.01
ATRI Per share dataATRI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • ATRI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. ATRI Dividend Analysis

5.1 Amount

  • ATRI has a Yearly Dividend Yield of 1.91%. Purely for dividend investing, there may be better candidates out there.
  • ATRI's Dividend Yield is rather good when compared to the industry average which is at 0.21. ATRI pays more dividend than 96.34% of the companies in the same industry.
  • ATRI's Dividend Yield is comparable with the S&P500 average which is at 1.82.
Industry RankSector Rank
Dividend Yield 1.91%

5.2 History

  • On average, the dividend of ATRI grows each year by 10.99%, which is quite nice.
  • ATRI has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ATRI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.99%
Div Incr Years20
Div Non Decr Years20
ATRI Yearly Dividends per shareATRI Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

5.3 Sustainability

  • 123.31% of the earnings are spent on dividend by ATRI. This is not a sustainable payout ratio.
  • The Dividend Rate of ATRI has been growing, while earnings will be declining. This means the dividend growth is most likely not sustainable.
DP123.31%
EPS Next 2YN/A
EPS Next 3YN/A
ATRI Yearly Income VS Free CF VS DividendATRI Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 0 10M 20M 30M
ATRI Dividend Payout.ATRI Dividend Payout, showing the Payout Ratio.ATRI Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ATRI Fundamentals: All Metrics, Ratios and Statistics

ATRION CORPORATION

NASDAQ:ATRI (8/20/2024, 8:22:19 PM)

459.92

+0.26 (+0.06%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)08-05
Earnings (Next)11-05
Inst Owners1.01%
Inst Owner Change0%
Ins Owners1.03%
Ins Owner Change0%
Market Cap809.46M
Revenue(TTM)181.60M
Net Income(TTM)12.56M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.91%
Yearly Dividend8.6
Dividend Growth(5Y)10.99%
DP123.31%
Div Incr Years20
Div Non Decr Years20
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 64.5
Fwd PE N/A
P/S 4.46
P/FCF 29.25
P/OCF 20.89
P/B 3.39
P/tB 3.55
EV/EBITDA 26.01
EPS(TTM)7.13
EY1.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)15.73
FCFY3.42%
OCF(TTM)22.02
OCFY4.79%
SpS103.18
BVpS135.72
TBVpS129.62
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA 4.82%
ROE 5.26%
ROCE 5.93%
ROIC 5.13%
ROICexc 5.53%
ROICexgc 5.81%
OM 7.93%
PM (TTM) 6.92%
GM 32.08%
FCFM 15.24%
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
ROICexc(3y)13.26%
ROICexc(5y)14.73%
ROICexgc(3y)13.99%
ROICexgc(5y)15.58%
ROCE(3y)13.12%
ROCE(5y)13.92%
ROICexgc growth 3Y-18.15%
ROICexgc growth 5Y-19.86%
ROICexc growth 3Y-17.93%
ROICexc growth 5Y-19.35%
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
F-Score6
Asset Turnover0.7
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 70.13%
Cap/Sales 6.1%
Interest Coverage 250
Cash Conversion 128.3%
Profit Quality 220.39%
Current Ratio 6.8
Quick Ratio 2.94
Altman-Z 25.99
F-Score6
WACC8.7%
ROIC/WACC0.59
Cap/Depr(3y)171.65%
Cap/Depr(5y)178.27%
Cap/Sales(3y)13.72%
Cap/Sales(5y)13.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.38%
EBIT growth 3Y-14.16%
EBIT growth 5Y-11.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.73%
OCF growth 3Y-20.1%
OCF growth 5Y-14.29%

ATRION CORPORATION / ATRI FAQ

What is the ChartMill fundamental rating of ATRION CORPORATION (ATRI) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ATRI.


What is the valuation status for ATRI stock?

ChartMill assigns a valuation rating of 3 / 10 to ATRION CORPORATION (ATRI). This can be considered as Overvalued.


How profitable is ATRION CORPORATION (ATRI) stock?

ATRION CORPORATION (ATRI) has a profitability rating of 6 / 10.


How sustainable is the dividend of ATRION CORPORATION (ATRI) stock?

The dividend rating of ATRION CORPORATION (ATRI) is 5 / 10 and the dividend payout ratio is 123.31%.